(Q42475930)

1 November 2017

title

Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome (English)

1 reference

1 November 2017

Tíras MB

1

1 reference

1 November 2017

Yalcìn R

2

1 reference

1 November 2017

Noyan V

3

1 reference

1 November 2017

Maral I

4

1 reference

1 November 2017

Yìldìrìm M

5

1 reference

1 November 2017

Dörtlemez O

6

1 reference

1 November 2017

Daya S

7

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

1 November 2017

1 reference

1 November 2017

volume

14

1 reference

1 November 2017

issue

8

1 reference

1 November 2017

page(s)

1949-1952

1 reference

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

The android woman--a risky condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Insulin resistance in nonobese patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Clinical implications of hyperinsulinaemia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Evidence for insulin resistance in nonobese patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Comparison of Doppler echocardiographic and hemodynamic indexes of left ventricular diastolic properties in coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Polycystic ovary syndrome and the androgen-insulin connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Mortality of women with polycystic ovary syndrome at long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Two-dimensional echocardiographic measurement of left ventricular ejection fraction: prospective analysis of what constitutes an adequate determination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Obesity, lipids, cardiovascular risk, and androgen excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F14.8.1949

21 January 2018

Identifiers

DOI

10.1093/HUMREP/14.8.1949

1 reference

1 November 2017

1 reference